AMATO, FELICE
 Distribuzione geografica
Continente #
EU - Europa 1.716
NA - Nord America 1.409
AS - Asia 581
AF - Africa 29
SA - Sud America 15
OC - Oceania 3
Totale 3.753
Nazione #
US - Stati Uniti d'America 1.383
IT - Italia 1.299
SG - Singapore 275
CN - Cina 200
NL - Olanda 117
VN - Vietnam 74
FR - Francia 56
FI - Finlandia 54
IE - Irlanda 54
DE - Germania 32
CI - Costa d'Avorio 29
CA - Canada 25
GB - Regno Unito 25
HU - Ungheria 16
BR - Brasile 15
IN - India 9
HK - Hong Kong 8
RU - Federazione Russa 8
BE - Belgio 7
MT - Malta 7
ES - Italia 6
CZ - Repubblica Ceca 5
IR - Iran 5
DK - Danimarca 4
AT - Austria 3
AU - Australia 3
GR - Grecia 3
LU - Lussemburgo 3
MK - Macedonia 3
UA - Ucraina 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
IL - Israele 2
JP - Giappone 2
KR - Corea 2
PK - Pakistan 2
PL - Polonia 2
SE - Svezia 2
CH - Svizzera 1
DO - Repubblica Dominicana 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
RO - Romania 1
TR - Turchia 1
Totale 3.753
Città #
Chandler 267
Singapore 227
Napoli 210
Naples 142
Santa Clara 104
Amsterdam 102
Ashburn 95
Dong Ket 74
Millbury 65
Beijing 48
Des Moines 47
Milan 46
Princeton 44
Nanjing 39
Boston 38
Rome 36
Lawrence 30
Ottawa 20
Wilmington 19
Tampa 17
Ercolano 15
Abbiategrasso 12
Helsinki 12
Bologna 11
Formia 11
Nanchang 10
Redwood City 10
Hebei 9
Jiaxing 9
Washington 9
Budapest 8
Marsala 8
Nocera Inferiore 8
Pavia 8
Shenyang 8
Ferrara 7
Melita 7
Melito Di Napoli 7
Norwalk 7
Castellammare Di Stabia 6
Dublin 6
Hangzhou 6
Hong Kong 6
Padova 6
Verona 6
Afragola 5
Cernusco Sul Naviglio 5
Como 5
Houston 5
Kensington 5
Lappeenranta 5
Molise 5
Natal 5
Pune 5
Szeged 5
Tianjin 5
Turin 5
Acerra 4
Bari 4
Changsha 4
Dallas 4
Guangzhou 4
London 4
Marano di Napoli 4
Munich 4
Palermo 4
San Felice A Cancello 4
Seattle 4
Seregno 4
Somma Vesuviana 4
Torino 4
Waanrode 4
Woodbridge 4
Avellino 3
Bournemouth 3
Brno 3
Cagliari 3
Camerino 3
Cogollo Del Cengio 3
Falkenstein 3
Florence 3
Grammichele 3
Gödöllő 3
Hagen 3
Højbjerg 3
Krefeld 3
Kunming 3
Los Angeles 3
Melito di Napoli 3
New York 3
Noale 3
Orta Nova 3
Parnamirim 3
Perugia 3
Piombino 3
Portici 3
Salerno 3
San Francisco 3
San Severo 3
Scafati 3
Totale 2.087
Nome #
Analisi qualitativa e quantitativa di splicing alternativi mediante una singola reazione di droplet digital PCR 360
MicroRNA come target terapeutici per il trattamento della fibrosi cistica 144
CFTR expression during cellular senescence 123
Clinical implication of cellular senescence on CFTR expression. 96
Gut Microbiota Features in Young Children with Autism Spectrum Disorders. [*Coretti L. corresponding author] 92
Corrigendum: Gut Microbiota Features in Young Children With Autism Spectrum Disorders 89
3D Chitosan-Gallic Acid Complexes: Assessment of the Chemical and Biological Properties 82
Enhanced frequency of CFTR gene variants in couples who are candidates for assisted reproductive technology treatment. 76
Epigenetica, diagnostica e terapia della fibrosi cistica 74
Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis 69
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis 66
Economical, legal and ethical considerations on reevaluation and retesting in molecular diagnostics 63
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles 59
Cystic Fibrosis: The Sense of Smell 59
Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis? 58
Comparative Evaluation of Nasal and Small Intestine Expression of ACE2, TMPRSS2 and ACE1 and in Children and in Adults 58
Cystic fibrosis, molecular genetics for all life 57
Cystic Fibrosis: the sense of smell. 57
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 56
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles 56
Tropomyosin-related kinase B receptor polymorphisms and isoforms expression in suicide victims 54
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization 54
CONVERSIONE GENICA FRA I GENI CODIFICANTI IL TRIPSINOGENO PRSS1 E PRSS2: UN EVENTO RICOMBINANTE RARO IN DUE PAZIENTI PEDIATRICI. 53
A Novel DHPLC-Based Procedure for the Analysis of COL1A1 and COL1A2 Mutations in Osteogenesis Imperfecta. 52
Two cases of microvillous inclusion disease caused by novel mutations in MYO5B gene 51
Olfactory performance in Cystic Fibrosis patients 50
Qualitative and quantitative evaluation of alternative splicing products using the digital droplet PCR 49
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods 47
Design, synthesis and biochemical investigation, by in vitro luciferase reporter system, of peptide nucleic acids as new inhibitors of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression 46
Valutazione degli effetti del butirrato sulla fisiologia intestinale mediante real-time PCR. 45
Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells 45
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 45
Twelve Novel Mutations in the SLC26A3 Gene in 17 Sporadic Cases of Congenital Chloride Diarrhea 43
The role of functional studies in the diagnosis and treatment of Cystic Fibrosis: comparing the case of the G970D and G970R mutation. 43
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 43
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality 42
Letter to the Editor: Is there an Indication for Testing the Methylenetetrahydrofolate reductase A1298C Variant in Routine Clinical Settings? 41
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis 39
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 39
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 39
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression 38
A novel de novo missense mutation in TP63 underlying germline mosaicism in AEC syndrome: Implications for recurrence risk and prenatal diagnosis. 37
High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel 37
Molecular analysis of prothrombotic gene variants in patients with acute ischemic stroke and with transient ischemic attack 37
TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. 36
Epigenetic effects of butyrate in children with congenital chloride diarrhea: an in-vivo and in-vitro study. 36
Analisi molecolare della nuova variante allelica T4Gnella regione 4G/5G del promotore del gene PAI-1. 36
Prothrombotic gene variants in acute myocardial infarction at a young age (yAMI). Rationale for tailored prevention strategies in specific risk-group subjects for acute coronary disease? 36
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 35
Extensive molecular analysis of patients bearing CFTR-related disorders. 34
Genetic Diseases That Predispose to Early Liver Cirrhosis 34
Haemophilia A: the consequences of de novo mutations. Two case reports 34
The friendly use of chloroquine in the COVID-19 disease: A warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene 34
Lung microbiome in cystic fibrosis 34
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in three subjects with the cystic fibrosis genotype phe508del/unknown and advanced lung disease 34
Target Protector PNA: a new tool in Cystic Fibrosis treatment 33
The implication of MBL deficient haplotypes in acute coronary syndrome. 32
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 32
Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment 31
Congenital diarrheal disorders: an updated diagnostic approach 31
Evaluation of butyrate efficacy in treatment of congenital chloride diarrhea: from genotype to clinical response. 31
Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium 30
Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype 30
Molecular and Functional Analysis of the Large 5' Promoter Region of CFTR Gene Revealed Pathogenic Mutations in CF and CFTR-Related Disorders. 29
Identificazionee caratterizzazione di mutazioni in regioni regolatorie del gene malattia della fibrosi cistica 26
Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea 25
Sars-cov-2: One year in the pandemic. What have we learned, the new vaccine era and the threat of sars-cov-2 variants 24
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 23
GENOTYPE PREDICTS THE RESPONSE TO THERAPY IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA. 23
Patient-derived cell models for personalized medicine approaches in cystic fibrosis 22
The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy 22
An Update on Laboratory Diagnosis of Liver Inherited Diseases 22
Ricerca di fattori trascrizionali allele specifici per due nuove varianti riscontrate nelle CSTs di CFTR. 22
A novel polymorphism in the PAI-1 gene promoter enhances gene expression. A novel pro-thrombotic risk factor? 22
Editorial Comment to p.Leu636Pro mutation is associated with cystic fibrosis transmembrane conductance regulator-related disorders (congenital bilateral absence of vas deferens) 21
BUTYRATE MODULATES EPITHELIAL DRA EXPRESSION IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA 20
The Kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control 20
Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2 19
Molecular and functional analysis of the promoter region of CFTR gene in CF and CFTR related disorders patients. 18
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 16
Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR 14
Identification of an ultra-rare Alu insertion in the CFTR gene: Pitfalls and challenges in genetic test interpretation 13
L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 12
Comprehensive Molecular Analysis of Disease-Related Genes as First-Tier Test for Early Diagnosis, Classification, and Management of Patients Affected by Nonsyndromic Ichthyosis 12
null 12
The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases 11
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 11
The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy 10
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 10
Mechanisms of action of butyrate in congenital chloride diarrhea (CLD) 3
Totale 3.978
Categoria #
all - tutte 15.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020147 0 0 0 0 0 5 12 7 19 54 32 18
2020/2021369 23 8 25 17 34 28 16 40 21 35 27 95
2021/2022707 51 27 14 26 7 32 13 37 93 113 127 167
2022/2023782 76 52 31 65 75 74 39 68 105 117 62 18
2023/2024623 29 77 90 43 39 59 36 59 27 32 72 60
2024/2025663 149 142 20 78 107 167 0 0 0 0 0 0
Totale 3.978